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Abstract
hair growth, weight gain and menstrual disorders. Women with PCOS are at higher 
Polycystic Ovary Syndrome (PCOS) affects 5-10% of women between the ages of 
15 and 44. These patients present with elevated androgenic hormones, excess 
risk for infertility, metabolic syndrome and heart and vascular diseases. Standard 
treatment for these patients includes prescription oral contraceptives (OCP) and 
metformin, but OCP have side effects of increased coagulopathy and risk of 
cardiovascular disease in an already at risk population and other adverse side 
effects. As even a modest weight loss of 2-5% has been shown to reduce 
symptoms, this paper aims to examine if a nutrition-focused diet is equally or more 
effective for weight loss and reduction of PCOS symptoms compared to current 
pharmacological treatments.
focused diets create successful outcomes and reduce the 
● ETIOLOGY of PCOS is unknown but genetics, obesity, excess insulin and 
low-grade inflammation have been shown to be factorial
● COMPLICATIONS include metabolic syndrome, cardiovascular disease, 
hypertension, elevated LDL, sleep apnea, depression, anxiety and 
endometrial cancer
● Insulin resistance is common
● >50% will develop diabetes or prediabetes before 40
● TREATMENT is 1st line lifestyle modification
● standard treatment includes OCP and Metformin
● 2-5% weight loss can restore menstrual regularity
● 5-10% weight loss can reduce androgen levels and decrease 
symptoms
● Can nutrition-
need for pharmacological treatment?
Introduction
Methods
 Literature search through PubMed, OVID, Medline and Biomedical Reference 
Collection on EBSCOhost
 Initial search terms “PCOS” OR “Polycystic ovarian syndrome” AND “diet”
 Filtered by articles published in the last 5 years
 Inclusions: “clinical trial” and “Randomized control trial” in humans
 Exclusions: studies strictly to increase fertility
 Six articles were chosen based on their applicability, study design, and 
relevant outcome measures
 Comparison search terms “PCOS” and “Metformin”
 Exclusions: Trials of metformin in combination with another Rx
 The two most relevant articles were chosen to provide comparison data
• Strengths
• Low glycemic index (LGI) diets, especially the DASH diet, showed significant reductions in weight, BMI, insulin resistance (HOMA-IR) and hs-
CRP compared to controls.
• Weight loss was greater in the 8-12 week dietary trials than in the 12-month metformin study. Significant reductions were seen in HOMA-IR in 
the dietary trials compared to the 24-month metformin study
• Insulin resistance is clinically significant as it contributes to many of the symptoms seen in PCOS
• Limitations
• Dietary studies are short-term, 8-12 weeks in length
• Many current trials are done in the setting of fertility
• High percentage of participants are lost to pregnancy/ follow up
• Direct comparison was difficult due to vast difference in study length
• No standardization of clinical success measures
• Longer studies of metformin lack a control group due to concern over lack of medical intervention in long-term studies
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• The literature review shows significant results for PCOS patients applying a nutrition-focused diet with reductions in weight, BMI, hs-CRP and insulin 
resistance. 
• Longer term studies are needed to determine if this success is sustainable and whether patients would continue to see reductions.
• The outcomes of these short-term trials are promising for clinical practice.
• Close work with a dietician able to create a plan that incorporates patient’s cultural and ethnic eating preferences and restrictions with these nutrition-
based changes could make this an achievable alternative to prescription medications.
• Ultimately this literature review did not yield a definitive answer to the efficacy of a nutrition-focused diet vs pharmacological treatment, but it 
highlights an area worthy of more research
Conclusion
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6 wks Substituting poly and mono-
unsaturated fat for dietary carbohydrates
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7 Yang et al (2018)
104 wks (24 mo) Metformin
N/A [S] -5% [NS] 0.09 [S] [NS] +0.2
P=<0.01
N/A [NS] B0.6 * 0.61
